KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Asset Writedowns and Impairment (2021 - 2025)

Nu Skin Enterprises' Asset Writedowns and Impairment history spans 5 years, with the latest figure at -$21.3 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment fell 163.19% year-over-year to -$21.3 million; the TTM value through Dec 2025 reached $3.8 million, down 97.9%, while the annual FY2025 figure was $3.8 million, 97.9% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was -$21.3 million at Nu Skin Enterprises, down from $19.3 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $143.8 million in Q3 2024 and bottomed at -$21.3 million in Q4 2025.
  • The 5-year median for Asset Writedowns and Impairment is $3.3 million (2023), against an average of $21.9 million.
  • The largest annual shift saw Asset Writedowns and Impairment skyrocketed 5234.5% in 2023 before it crashed 1373.17% in 2025.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $13.7 million in 2021, then crashed by 112.53% to -$1.7 million in 2022, then surged by 5234.5% to $88.1 million in 2023, then crashed by 61.73% to $33.7 million in 2024, then tumbled by 163.19% to -$21.3 million in 2025.
  • Per Business Quant, the three most recent readings for NUS's Asset Writedowns and Impairment are -$21.3 million (Q4 2025), $19.3 million (Q3 2025), and -$19.3 million (Q2 2025).